2-26191048-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000182.5(HADHA):​c.*202G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.779 in 644,272 control chromosomes in the GnomAD database, including 195,983 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45038 hom., cov: 32)
Exomes 𝑓: 0.78 ( 150945 hom. )

Consequence

HADHA
NM_000182.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.73

Publications

15 publications found
Variant links:
Genes affected
HADHA (HGNC:4801): (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) This gene encodes the alpha subunit of the mitochondrial trifunctional protein, which catalyzes the last three steps of mitochondrial beta-oxidation of long chain fatty acids. The mitochondrial membrane-bound heterocomplex is composed of four alpha and four beta subunits, with the alpha subunit catalyzing the 3-hydroxyacyl-CoA dehydrogenase and enoyl-CoA hydratase activities. Mutations in this gene result in trifunctional protein deficiency or LCHAD deficiency. The genes of the alpha and beta subunits of the mitochondrial trifunctional protein are located adjacent to each other in the human genome in a head-to-head orientation. [provided by RefSeq, Jul 2008]
GAREM2 (HGNC:27172): (GRB2 associated regulator of MAPK1 subtype 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-26191048-C-T is Benign according to our data. Variant chr2-26191048-C-T is described in ClinVar as [Benign]. Clinvar id is 335372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HADHANM_000182.5 linkc.*202G>A 3_prime_UTR_variant Exon 20 of 20 ENST00000380649.8 NP_000173.2 P40939-1E9KL44
GAREM2XM_011532567.4 linkc.1683+3733C>T intron_variant Intron 6 of 6 XP_011530869.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HADHAENST00000380649.8 linkc.*202G>A 3_prime_UTR_variant Exon 20 of 20 1 NM_000182.5 ENSP00000370023.3 P40939-1

Frequencies

GnomAD3 genomes
AF:
0.770
AC:
116987
AN:
152002
Hom.:
45019
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.753
Gnomad AMI
AF:
0.724
Gnomad AMR
AF:
0.781
Gnomad ASJ
AF:
0.690
Gnomad EAS
AF:
0.847
Gnomad SAS
AF:
0.777
Gnomad FIN
AF:
0.704
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.785
Gnomad OTH
AF:
0.774
GnomAD4 exome
AF:
0.782
AC:
384750
AN:
492152
Hom.:
150945
Cov.:
4
AF XY:
0.781
AC XY:
204154
AN XY:
261286
show subpopulations
African (AFR)
AF:
0.754
AC:
10840
AN:
14368
American (AMR)
AF:
0.783
AC:
22724
AN:
29010
Ashkenazi Jewish (ASJ)
AF:
0.677
AC:
10697
AN:
15802
East Asian (EAS)
AF:
0.876
AC:
27439
AN:
31318
South Asian (SAS)
AF:
0.768
AC:
39570
AN:
51528
European-Finnish (FIN)
AF:
0.723
AC:
22066
AN:
30502
Middle Eastern (MID)
AF:
0.744
AC:
1595
AN:
2144
European-Non Finnish (NFE)
AF:
0.788
AC:
228306
AN:
289720
Other (OTH)
AF:
0.775
AC:
21513
AN:
27760
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4562
9124
13687
18249
22811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1078
2156
3234
4312
5390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.770
AC:
117059
AN:
152120
Hom.:
45038
Cov.:
32
AF XY:
0.766
AC XY:
56945
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.753
AC:
31257
AN:
41502
American (AMR)
AF:
0.781
AC:
11951
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.690
AC:
2391
AN:
3466
East Asian (EAS)
AF:
0.846
AC:
4368
AN:
5162
South Asian (SAS)
AF:
0.777
AC:
3746
AN:
4822
European-Finnish (FIN)
AF:
0.704
AC:
7452
AN:
10578
Middle Eastern (MID)
AF:
0.731
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
0.785
AC:
53393
AN:
67982
Other (OTH)
AF:
0.772
AC:
1627
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1420
2840
4260
5680
7100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.777
Hom.:
12762
Bravo
AF:
0.774

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mitochondrial trifunctional protein deficiency Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.48
DANN
Benign
0.68
PhyloP100
-1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7260; hg19: chr2-26413917; API